Call Options Transactions Made in Q1 2024 in I Teos Therapeutics, Inc. (ITOS)
This table provides information about the institutional ownership of I Teos Therapeutics, Inc. (ITOS) during Q1 2024. The information is specifically focused on institutions that hold call options of iTeos Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
CALL |
31.4KNew |
$311K - $428K
|
31.4K
$251K
|
|
|
May 15, 2024
Q1 2024
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
15.3KNew |
$151K - $209K
|
15.3K
$122K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
11K+ 523.81% |
$109K - $150K
|
13.1K
$105K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-82.6K- 76.91% |
$817K - $1.13M
|
24.8K
$198K
|